ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,720,320 | -18.8% | 4,573,440 | +1.2% | 0.00% | – |
| Q2 2023 | $16,895,820 | +9.9% | 4,517,599 | -1.5% | 0.00% | – |
| Q1 2023 | $15,367,057 | -47.5% | 4,587,181 | -24.7% | 0.00% | -100.0% |
| Q4 2022 | $29,290,601 | -32.1% | 6,089,522 | -19.7% | 0.00% | 0.0% |
| Q3 2022 | $43,155,000 | -15.3% | 7,584,256 | +5.6% | 0.00% | 0.0% |
| Q2 2022 | $50,980,000 | +4.9% | 7,180,285 | +6.7% | 0.00% | 0.0% |
| Q1 2022 | $48,584,000 | -6.0% | 6,729,203 | +16.4% | 0.00% | 0.0% |
| Q4 2021 | $51,690,000 | -71.5% | 5,781,882 | +11.6% | 0.00% | -80.0% |
| Q3 2021 | $181,608,000 | +86.4% | 5,179,955 | +14.2% | 0.01% | +150.0% |
| Q2 2021 | $97,437,000 | +42.6% | 4,536,163 | +309.8% | 0.00% | 0.0% |
| Q1 2021 | $68,351,000 | +50.8% | 1,106,905 | +2.1% | 0.00% | +100.0% |
| Q4 2020 | $45,312,000 | – | 1,084,527 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |